Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISAR-SAFE: 6 vs 12 Months Clopidogrel After DES
NCT00661206Phase 4Unknown
- Sponsor
- Deutsches Herzzentrum München
- Start
- Sep 2008
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 4 trial of clopidogrel in coronary artery disease (CAD), sponsored by Deutsches Herzzentrum München. Status: unknown.
02
Drugs
clopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00661206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00661206.